CENGILD Stock Overview
Cengild Medical Berhad, an investment holding company, engages in the operation of medical centers in Malaysia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Cengild Medical Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM0.32 |
| 52 Week High | RM0.47 |
| 52 Week Low | RM0.28 |
| Beta | 0 |
| 1 Month Change | 10.53% |
| 3 Month Change | 6.78% |
| 1 Year Change | -31.52% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -32.26% |
Recent News & Updates
Shareholder Returns
| CENGILD | MY Healthcare | MY Market | |
|---|---|---|---|
| 7D | -4.5% | 0.2% | -1.6% |
| 1Y | -31.5% | 7.4% | 8.4% |
Return vs Industry: CENGILD underperformed the MY Healthcare industry which returned 7.4% over the past year.
Return vs Market: CENGILD underperformed the MY Market which returned 8.4% over the past year.
Price Volatility
| CENGILD volatility | |
|---|---|
| CENGILD Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 3.7% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in MY Market | 10.8% |
| 10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: CENGILD has not had significant price volatility in the past 3 months.
Volatility Over Time: CENGILD's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 130 | Michael Bong | www.cengild.com |
Cengild Medical Berhad, an investment holding company, engages in the operation of medical centers in Malaysia. The company provides various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; and general cardiology and gynecology assessment, gastroenterology, and hepatology, as well as gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric surgery. It also provides medical management services, such as nursing services and clinical support services comprising radiology for advanced imaging, pharmacy for precise medication management, clinical laboratory for diagnostic tests, dietetics and nutrition expertise, physiotherapy for rehabilitation, and meticulous medical record services.
Cengild Medical Berhad Fundamentals Summary
| CENGILD fundamental statistics | |
|---|---|
| Market cap | RM262.37m |
| Earnings (TTM) | RM12.02m |
| Revenue (TTM) | RM67.10m |
21.8x
P/E Ratio3.9x
P/S RatioIs CENGILD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CENGILD income statement (TTM) | |
|---|---|
| Revenue | RM67.10m |
| Cost of Revenue | RM36.83m |
| Gross Profit | RM30.27m |
| Other Expenses | RM18.25m |
| Earnings | RM12.02m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.014 |
| Gross Margin | 45.11% |
| Net Profit Margin | 17.91% |
| Debt/Equity Ratio | 0% |
How did CENGILD perform over the long term?
See historical performance and comparison